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Spinal muscular atrophy (SMA) is a rare genetic disease characterized by degeneration of spinal cord motor neurons, which
results in hypotonia and muscle weakness. Patients with type IV SMA often have onset of weakness from adulthood. Anesthetic
management is often diﬃcult in these patients as a result of muscle weakness and hypersensitivity to neuromuscular blocking
agents as shown by (Lunn and Wang; 2008, Simic; 2008, and Cifuentes-Diaz et al.; 2002). Herein we report a case of anesthetic
management of a patient with SMA type IV for mammectomy and review some other cases of SMA patients receiving diﬀerent
kinds of anesthesia.
1.CaseReport
A 41-year-old woman (height 1.66m; weight 62kg) with
SMAtypeIVwasscheduledformammectomy.Thediagnosis
of SMA type IV was based on clinical progressive symptoms
of limb muscular weakness that began eight years ago. She
has been on wheelchair since ﬁve years ago. At present,
she even could not lift her arms up but had no diﬃculty
in swallowing or breathing. She had a family history of
SMA, her mother (died at 50 years old) and uncle both
had the same disease. She had resection of right breast
ﬁbroadenoma under local anesthesia 6 years ago and right
oophorocystectomy under epidural anesthesia 12 years ago.
Physical examination revealed that she had a hoarse throat,
normal gape degree, proximal muscular atrophy of the
limb, muscular strength 2–4 degrees (with 4 degrees in the
upper limb and 2 degrees in the lower limb), decreases of
tendon reﬂex in extremities, no pyramidal tract signs, and
paraesthesia.ChestX-rayshowedincreasesinlungmarkings.
ECG was normal. The laboratory examinations were normal
except serum creatinine 31.00µmol/L (normal value is
44–133µmol/L). Bronchoﬁberscopy showed limitation of
vocal fold abduction. A size 6 cm × 6cm lump (benign
ﬁber-epithelial tumor conﬁrmed by a biopsy pathological
examination) was found in her right breast, and at her
request, her admission was scheduled to remove her right
breast in fear of malignancy in the future.
On the operating day, no premedication was given to the
patient. Electrocardiogram, cuﬀed blood pressure, and SpO2
were monitored. External jugular vein was inserted with an
18ga catheter due to collapse of extremity veins. Anesthesia
was induced with remifentanil (target-controlled infusion
at plasma concentration of 3ng/mL) and propofol (target-
controlled infusion at plasma concentration of 3µg/mL) and
a size 4 laryngeal mask airway (LMA) was tried to but failed.
Then rocuronium 30mg was given to facilitate the endotra-
chealintubation.Thepatientwasintubatedwithaninsertion
of a size 7 endotracheal tube. Anesthesia was maintained
with intravenous remifentanil (target-controlled infusion
at plasma level of 2-3ng/mL), propofol (target-controlled
infusion at plasma level of 3-4µg/mL), and 50% nitrous
oxide balanced with oxygen. The hemodynamic parameters
werestableduring the one-hoursurgery.Morphine 3mg was
given intravenously 30 minutes before the end of operation.
The patient woke up quickly after cessation of anesthesia
and could raise her head. Antagonists of muscle relaxant
(neostigmine 2mg plus atropine 1mg) were given. She was
extubated and transferred to the surgical intensive care unit2 Case Reports in Anesthesiology
(SICU), where she recovered uneventfully. She returned to
the general ward on the following day and was discharged
from hospital 5 days after operation.
2. Discussion
SMA was ﬁrst described by Guido Werdnig at the end of
the nineteenth century and was divided into four types
according to age at onset and severity. The suﬀeres of
SMA type I and II are mainly infants and SMA type III
are toddlers and teenagers. SMA type IV is a rare adult
form with an incidence <0.5/10000 and is a milder form,
which is inherited in either an autosomal dominant or rarely
autosomal recessive manner. Patients with this type have
a normal life expectancy, and motor impairment is mild
without respiratory or nutritional problems [1–3].
SMA is characterized by degeneration of motor neurons
of the spinal cord, which results in hypotonia, muscle
weakness and atrophy (especially of the proximal muscles of
the shoulder and pelvic girdle), and absence of deep tendon
reﬂexes, with little or no impairment of sensory systems
and the diaphragm and extraocular muscles remaining
unaﬀected until the late stages of the disease. The diagnosis
of SMA needs to be conﬁrmed by electromyography and
muscle biopsy. The pathology shows muscle degeneration,
atrophic ﬁbers with islands of group hypertrophy, and severe
loss of motor neuron in the anterior horn region. Although
there is no eﬀective medical treatment for SMA at present,
recent studies have elucidated the possible mechanisms of
this disease development, and the therapeutic strategies have
been identiﬁed and are in various stages of development [1–
4].
The management of anesthesia in patients with SMA
is often diﬃcult because of muscle weakness, anesthesia-
induced respiratory complications, hypersensitivity to non-
depolarizing muscle relaxants, and succinylcholine-induced
hyperkalemia. Also worries of neuraxial (epidural or spinal)
blocks could worsen the weakness. Very little information
is available in the anesthetic textbooks regarding the man-
agement of such cases although it was indicated that muscle
relaxants, opioids, and thiopental could all have a prolonged
duration of action [5, 6].
Several cases were reported about anesthetic manage-
ment of patients with SMA without using muscle relaxants.
Watts [6] reported a 25-year-old female with SMA type III
presented for urgent corneal grafting due to keratoglobus
under general anesthesia. Anesthesia was induced using
alfentanil and propofol. After insertion of laryngeal mask
airway (LMA), anesthesia was maintained with propofol
and remifentanil infusions; controlled ventilation was main-
tained throughout the operation without muscle relaxants.
Spontaneous respiration returned almost immediately the
infusions that were stopped, and LMA was removed within
5min.Theauthorsuggestedthattotalintravenousanesthesia
(TIVA) may provide an ideal anesthetic regimen for such
patients. Habib et al. [7] reported a 23-year-old parturient of
SMA type II undergoing elective cesarean section (CS) with
general anesthesia (she had severe kyphoscoliosis and ﬁve
Harrington rods inserted before she was ten). Anesthesia was
induced with alfentanil and propofol, cricoid pressure was
applied, and endotracheal tube was easily inserted without
muscle relaxants. Anesthesia was maintained using 50%
nitrous oxide in oxygen and 0.5–1% isoﬂurane; intraop-
erative analgesia was provided using morphine 6mg given
after delivery. The trachea was extubated at the end of the
procedure, and the patient was transferred to the SICU.
Following an overnight stay in the SICU and being moved
to general labor ward, she was discharged 5 days later. The
authors suggested that succinylcholine was classically used
for rapid-sequence induction of anesthesia in the obstetric
population. However, its use was contraindicated in patients
with SMA because of the high risk of life-threatening hyper-
kalemia and rhabdomyolysis, and the use of nondepolarizing
muscle relaxants needs also to be avoided. An increase of
sensitivity to these drugs had been described in some lower
motor neurone dysfunction caused by impaired production
of choline accetyltransferase and acetylcholinesterase, and
reduced concentration of acetylcholine at the endplate. An
alternative method to achieve rapid-sequence induction
without muscle relaxants was propofol-remifentanil tech-
nique. Kitson et al. [8] reported a 38-year-old type III SMA
parturient receiving CS who had a history of tracheostomy
during previous pregnancy. So she had a known failed
intubation (hence the previous tracheostomy) and received
awake ﬁbreoptic intubation (FOI). Anesthesia was induced
with alfentanil and propofol and maintained with isoﬂurane,
nitrous oxide, and oxygen without muscle relaxants. She was
extubated soon after the operation and placed onto a CPAP
circuit. She recovered well and was discharged home 2 days
later.
There also existed several case reports using muscle
relaxants during general anesthesia. A 24-year-old female
withtypeIIISMAat38weeks’gestationwasadmittedforCS.
Premedication included oral ranitidine 300mg plus meto-
clopramide 10mg. Anesthesia was induced with thiopentone
and rocuronium; laryngoscopy and tracheal intubation
proceeded uneventfully. Anesthesia was maintained by inter-
mittent positive pressure ventilation with 50% nitrous oxide
in oxygen with isoﬂurane 1%. With the exception of fentanyl
100µg administered after the delivery of the baby, no opi-
ates were given intraoperatively. Reversal of neuromuscular
blockage was not attempted until at least 40min had passed
from the administration of rocuronium. After neostigmine
was given, spontaneous respiration quickly returned and
anesthesia was discontinued. After regaining consciousness
and despite adequate spontaneous respiration without dysp-
nea,therewasmarkedresidualweaknessofthemusclesofthe
upper limbs, head, and neck. The patient was transferred to
SICU where she regained her preanesthetic pattern of muscle
weakness after 8h. She was transferred to the postnatal ward
24h later and was discharged home one week later [9].
The author chose rocuronium for neuromuscular blockage
as it allowed satisfactory intubating conditions after 60s
and had been used as an alternative to succinylcholine in
obstetric anesthesia. Stucke and Stuth [10]ﬁ r s tr e p o r t e d
the use of a nondepolarizing neuromuscular blocking agent
in an 18-month-old child with SMA (either mild type I
or severe type II). Thiopental and alfentanil were used forCase Reports in Anesthesiology 3
anesthetic induction; a premature attempt at direct laryn-
goscopy provoked laryngospasm and inability to ventilate,
so rapacuronium 9mg (1mgkg−1) was given. Within 60s,
ventilation by mask was restored and the child was intubated
without diﬃculties. Within 15min, the authors observed
some diaphragmatic recovery, and after emergence from
anesthesia, the child showed adequate respiratory eﬀects but
diminished strength of the upper extremity muscles. Small
dose of midazolam was given to reduce the anxiety, and the
patient was extubated within 5h without any complications.
They suggested that the pronounced diﬀerence in recovery
times of the diaphragm and the upper limb muscles in the
patient be most likely due to the diﬀerent involvement of
these muscle groups in the primary disease.
In other cases, spinal, epidural, or combined spinal and
epidural(CSE)anesthesiawasselectedforSMApatientsdur-
inglabor(eitherforCSorforlaboranalgesia).Itwasbelieved
that parturients with SMA presented several problems for
anesthesiologists. General anesthesia was complicated by
underlyingrestrictivelungdisease,sensitivitytonondepolar-
izing muscle relaxants, potential for hyperkalemia with suc-
cinylcholine and likelihood of diﬃcult intubation. Regional
anesthesia can be technically diﬃcult. Epidural anesthesia
may fail due to inadequate spread of local anesthetics,
particularly if there had been corrective back surgery. Dose
requirements for spinal anesthesia were diﬃcult to predict,
increasing the risk of either a failed or high block. CSE or
continuousspinaltechniquemayallowtheblockheighttobe
titrated more carefully and should be considered ideal [11–
15].
In our case, nondepolarizing muscle relaxant was used,
and the time of onset and recovery of rocuronium remained
in the normal range. The patient was extubated shortly
after the operation and did not develop prolonged muscle
weakness as in the other cases using muscle relaxants [9, 10].
The reason may be that these patients had diﬀerent types of
SMA,inwhichourpatienthadtypeIVSMA,withlateronset
and a milder impairment of motor function. In conclusion,
nondepolarizing muscle relaxants could be used safely in
SMA type IV patients, with the combined target-controlled
infusion of remifentanil and propofol (TIVA), providing an
ideal condition for anesthetic induction and maintenance.
On considering recovery of muscle strength after anesthesia,
it is advisable that train of four (TOF) monitoring should be
carried out to secure the patients with SMA.
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